‹ Home
Exported

OD2A Innovative Surveillance CoP Workgroup Resource Repository

ABOUT THIS COMMUNITY OF PRACTICE In partnership with the National Center for Injury Prevention and Control (NCIPC), the Council of State and Territorial Epidemiologists (CSTE) hosts this community of practice among OD2A-funded jurisdictions currently conducting innovative surveillance projects. This OD2A Innovative Surveillance Community of Practice consists of 3 focused workgroups that provide a forum for peer discussion on cross-cutting topics, methods, and challenges/solutions across jurisdictions. ______________________________________________________________________________________________________________________ USING THIS BASECAMP + This Basecamp is a tool that houses previous call slides/recordings and allows members to engage with peers. + The Q/A section may be used to facilitate connections/discussion among members. Engagement could include posting new questions/discussion topics or replying to peer questions/discussions. + Members are encouraged to share helpful resources for peers. Members may post any publicly available resource in this space. Please do not share any proprietary information or upload private documents. _________________________________________________________________________________________________________ CONTACT US Email staff lead, Danielle Boyd (overdose@cste.org) if you have questions about the Innovative Surveillance CoP or about this basecamp site for the group. Join the Innovative Surveillance CoP Listserve HERE: https://app.smartsheet.com/b/form/4a5b9c8d52294a67ae920fca78c6c111
Megan Toe, CSTEDanielle Boyd, Program Analyst at CSTEMamadou NdiayeFan XiongErin Stokes, Morbidity Science Officer, CDC/NCIPC/DOPCailyn Lingwall, Program Analyst at CSTELizette BrenesMarcus Rennick, Consultant at Kahuina ConsultingEmily HostermanStephen Liu, Health ScientistDesiree MustaquimClaire NguyenStella TsaiKara ManchesterStacey Hoferka Jensen +80 others
Posted by Danielle Boyd ·

Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic

At the start of the year, CDC NCIPC published the paper Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic looking at how buprenorphine-involved overdose death trends changed under expanded access and prescribing flexibilities during the COVID-19 pandemic. Using data from CDC’s State Unintentional Drug Overdose Reporting System (SUDORS), the report, authored by CDC and NIDA, found that expanded access to buprenorphine did not result in an increased proportion of opioid overdose deaths involving buprenorphine. This has important implications when policymakers consider further expanding access to buprenorphine, such as the passage of the MAT Act in the recent omnibus spending bill. CDC NCIPC hopes that scientific findings such as these can support federal, state, and local efforts to expand access to medication for opioid use disorder and improve racial, socioeconomic, and rural/urban disparities in access to those evidence-based treatments.